Local Anesthetic Injection Into Both Angles of the Rectus Sheath Incision
NCT ID: NCT02285491
Last Updated: 2016-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
225 participants
INTERVENTIONAL
2014-11-30
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine
NCT02274974
Subarachnoid Administration of Levobupivacaine for Cesarean Section
NCT01582607
Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief
NCT04538391
Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery
NCT02829944
Wound Infiltration of Liposomal Bupivacaine v Plain Bupivacaine for Post-Op Pain Control in Elective Cesarean Delivery
NCT03353363
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bupivacaine group
This is the group of patients that will receive 10ml of bupivacaine 0.5% injection in both angles of the rectus sheath incision
10ml of bupivacaine 0.5%
This is a local anesthetic that will be used to block the ilioinguinal nerve to alleviate pain at the wound site after lscs
saline group
This group will receive saline injections as placebo into both angles of the rectus sheath incision
Placebo
10 ml of saline will be injected as a placebo and the investigator and the patient and the data assessor are all blinded to what the patients received.
bupivacaine and saline group
This group will receive saline injection in one angle and 10ml of bupivacaine 0.5% injection in the opposite angle.
10ml of bupivacaine 0.5%
This is a local anesthetic that will be used to block the ilioinguinal nerve to alleviate pain at the wound site after lscs
Placebo
10 ml of saline will be injected as a placebo and the investigator and the patient and the data assessor are all blinded to what the patients received.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
10ml of bupivacaine 0.5%
This is a local anesthetic that will be used to block the ilioinguinal nerve to alleviate pain at the wound site after lscs
Placebo
10 ml of saline will be injected as a placebo and the investigator and the patient and the data assessor are all blinded to what the patients received.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* primisection
* singleton pregnancy
Exclusion Criteria
* bleeding tendency
* hypersensitivity to local anesthetic
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams Maternity Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
dr mohammed elsafty
Dr Mohammed Elsafty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams Maternity Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
els7680
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.